Children's Hospital of Orange County

Children's Hospital of Orange County was paid $53.69M by Medicaid between Jan 2018 and Dec 2024, across 598 billing codes. Its largest line is 90378, — 22% of everything it billed.

33Billing provider infoCHILDREN'S HOSPITAL OF ORANGE COUNTY
ORANGE, CA 92868

33aNPI1811080526assigned 10/02/2006

33bProvider typeUrgent Care Clinic/Center

28Total paid$53.69M

24GClaims2,772,398

24DCodes billed598

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in California

Rank by total paid#4 of 284

Median peer was paid$147K

This provider vs. median364×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	339,146	$4.09M
2019	370,476	$5.82M
2020	326,553	$7.29M
2021	386,294	$7.80M
2022	454,850	$8.44M
2023	480,571	$9.92M
2024incomplete	414,508	$10.32M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
90378		22%	3,931	2,543	$11.75M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	8.7%	2,081	1,574	$4.69M
0450	Emergency room services	7.1%	323,737	297,210	$3.81M
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	5.6%	399	287	$2.99M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.8%	13,895	13,558	$2.06M
J3262	Injection, tocilizumab, 1 mg	3.2%	801	476	$1.73M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2.8%	1,194	613	$1.48M
Z7500		1.8%	27,623	26,702	$941K
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	1.7%	76,126	62,060	$930K
Z7502		1.6%	23,850	23,700	$882K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.4%	9,087	8,480	$730K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	6,029	5,839	$687K

586 more codes

93975		1.2%	10,941	$663K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.1%	27,766	$604K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	17,601	$532K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	23,522	$519K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	17,026	$494K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	4,410	$470K
J3490	Unclassified drugs	<1%	82,465	$450K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	15,472	$442K
80053	Comprehensive metabolic panel	<1%	79,443	$436K
0123		<1%	103	$402K
99199	Unlisted special service, procedure or report	<1%	27,141	$395K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	3,512	$384K
0760		<1%	131,623	$378K
0510		<1%	52,310	$366K
95782		<1%	854	$350K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	12,503	$346K
70450	Computed tomography, head or brain; without contrast material	<1%	7,795	$346K
71046	Radiologic examination, chest; 2 views	<1%	34,176	$337K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	14,202	$316K
96361	Intravenous infusion, hydration; each additional hour	<1%	17,607	$271K
76770		<1%	13,315	$269K
87634		<1%	9,710	$245K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	4,822	$239K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	14,006	$224K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	20,916	$206K
99221		<1%	815	$201K
0360		<1%	26,827	$201K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	3,649	$192K
87428		<1%	5,752	$190K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	18,116	$189K
96450		<1%	1,803	$188K
87086	Culture, bacterial; quantitative colony count, urine	<1%	48,585	$185K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	687	$179K
87581		<1%	14,138	$178K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	39,907	$178K
87486		<1%	14,138	$178K
99215	Doctor's office visit, returning patient (complex)	<1%	2,885	$166K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	44,093	$164K
J2704	Injection, propofol, 10 mg	<1%	23,253	$164K
96375	Therapeutic injection; each additional sequential IV push	<1%	16,398	$158K
J0558	Injection, penicillin g benzathine and penicillin g procaine, 100,000 units	<1%	861	$149K
Z4300		<1%	1,429	$148K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	50,585	$145K
96112		<1%	4,960	$144K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	1,516	$139K
0361		<1%	5,113	$138K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	22,544	$125K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,762	$123K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,463	$117K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	24,063	$113K
0710		<1%	25,853	$101K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	6,526	$101K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	8,200	$96K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,567	$95K
Z7610		<1%	8,697	$89K
86140		<1%	40,860	$88K
87040		<1%	14,471	$87K
97750		<1%	11,436	$85K
41899	Unlisted procedure, dentoalveolar structures	<1%	1,844	$84K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,700	$76K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	22,123	$76K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,543	$74K
74018		<1%	9,076	$73K
Z7506		<1%	529	$72K
99070		<1%	4,716	$72K
81001		<1%	50,607	$71K
99238	Hospital discharge day management, 30 minutes or less	<1%	1,446	$71K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	8,613	$68K
97165		<1%	4,048	$68K
95819		<1%	5,619	$67K
85027		<1%	24,710	$67K
96409		<1%	5,433	$67K
G0378	Hospital observation service, per hour	<1%	547	$67K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	20,489	$66K
J9370	Vincristine sulfate, 1 mg	<1%	4,816	$66K
80306		<1%	8,140	$65K
92521		<1%	906	$63K
71045	Radiologic examination, chest; single view	<1%	6,800	$63K
73610		<1%	11,496	$63K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,919	$61K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,977	$61K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,833	$60K
76536		<1%	3,517	$59K
76870		<1%	4,593	$58K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	12,505	$57K
94375		<1%	11,682	$57K
44970		<1%	774	$55K
73080		<1%	8,681	$55K
99222	Initial hospital care, per day, moderate complexity	<1%	436	$54K
73521		<1%	6,624	$54K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,128	$52K
73630		<1%	9,162	$52K
99245		<1%	548	$51K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	4,097	$51K
99499		<1%	873	$51K
0160		<1%	5,908	$50K
83690		<1%	16,112	$50K
Z4307		<1%	2,055	$50K
85007		<1%	32,308	$49K
83615		<1%	17,928	$49K
Z4301		<1%	1,934	$49K
73110		<1%	8,403	$48K
96111		<1%	458	$48K
73562		<1%	8,701	$48K
96379		<1%	8,881	$47K
72082		<1%	5,466	$46K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,535	$45K
92570		<1%	943	$44K
74022		<1%	2,656	$43K
97533		<1%	821	$43K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,361	$42K
99214	Doctor's office visit, returning patient (more involved)	<1%	873	$42K
T1024	Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter	<1%	16,237	$42K
83036	Hemoglobin; glycosylated (A1C)	<1%	12,527	$42K
70486		<1%	1,160	$42K
84100		<1%	17,916	$41K
97139		<1%	15,296	$40K
73130		<1%	6,898	$40K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	970	$39K
73090		<1%	7,199	$38K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	985	$37K
Z4308		<1%	1,503	$36K
0762		<1%	1,147	$36K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,588	$36K
92587		<1%	559	$35K
73590		<1%	5,754	$34K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	2,797	$34K
84550		<1%	15,637	$33K
76000		<1%	3,585	$32K
97802		<1%	1,046	$32K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,049	$32K
0270		<1%	49,922	$31K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	2,257	$31K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	28	$31K
92558		<1%	668	$31K
82803		<1%	4,592	$30K
87430		<1%	7,782	$30K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,917	$29K
99366		<1%	19,897	$28K
99232	Hospital visit by a doctor, follow-up day	<1%	519	$28K
74183		<1%	294	$28K
0300		<1%	1,988	$28K
73552		<1%	3,074	$28K
83605		<1%	5,058	$27K
85055		<1%	2,508	$27K
84443	Thyroid stimulating hormone (TSH)	<1%	7,095	$27K
82330		<1%	4,418	$26K
0636		<1%	2,213	$26K
83880		<1%	2,043	$26K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,998	$26K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,222	$25K
87186		<1%	7,071	$25K
87497		<1%	600	$25K
81025		<1%	15,094	$25K
86923		<1%	1,935	$25K
93325		<1%	547	$25K
97803		<1%	2,245	$25K
83735		<1%	6,362	$24K
95811		<1%	345	$24K
0250		<1%	2,894	$23K
99218		<1%	93	$23K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	830	$23K
87081		<1%	10,109	$23K
70491		<1%	344	$22K
85652		<1%	16,319	$22K
0301		<1%	1,245	$22K
G9002	Coordinated care fee, maintenance rate	<1%	2,668	$22K
72157		<1%	256	$22K
Z4311		<1%	1,811	$22K
72158		<1%	401	$21K
92588		<1%	286	$20K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	350	$20K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,075	$20K
96415		<1%	2,120	$19K
85730		<1%	5,791	$19K
Z4309		<1%	730	$19K
87077		<1%	5,754	$19K
J9260	Injection, methotrexate sodium, 50 mg	<1%	2,005	$19K
99243		<1%	210	$19K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,111	$18K
12011		<1%	3,189	$18K
84145		<1%	1,173	$18K
88313		<1%	675	$17K
43762		<1%	626	$17K
85379		<1%	3,179	$17K
73030		<1%	2,637	$17K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,788	$16K
V5298	Hearing aid, not otherwise classified	<1%	12	$16K
Z4302		<1%	1,143	$16K
Z4312		<1%	1,338	$16K
95012		<1%	6,354	$16K
86850		<1%	6,201	$16K
54161		<1%	818	$15K
85610		<1%	6,344	$15K
73140		<1%	4,937	$15K
85384		<1%	3,096	$15K
70543		<1%	191	$14K
72197		<1%	227	$14K
76885		<1%	398	$14K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,681	$14K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	735	$14K
72100		<1%	2,525	$14K
94799		<1%	1,789	$14K
72156		<1%	227	$14K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	327	$14K
81002		<1%	19,049	$14K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	691	$14K
73000		<1%	2,731	$14K
84439		<1%	6,750	$13K
82728		<1%	3,905	$13K
96411		<1%	978	$13K
97010		<1%	6,037	$13K
72125	Computed tomography, cervical spine; without contrast material	<1%	199	$12K
84484		<1%	2,914	$12K
82550		<1%	5,403	$12K
70360		<1%	2,982	$12K
74019		<1%	812	$12K
Z4310		<1%	985	$12K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	2,546	$12K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	367	$12K
87070		<1%	3,320	$12K
Z7512		<1%	446	$12K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	<1%	2,761	$12K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	941	$12K
84305		<1%	1,197	$11K
0258		<1%	119	$11K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	390	$11K
76010		<1%	1,206	$10K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	11,732	$10K
86900		<1%	6,316	$10K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	120	$10K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	515	$10K
94770		<1%	1,167	$10K
80299		<1%	1,453	$9K
70480		<1%	201	$9K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	703	$9K
88312		<1%	2,294	$9K
92060		<1%	185	$9K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,212	$9K
86901		<1%	6,308	$9K
73060		<1%	1,646	$9K
0306		<1%	1,280	$9K
73070		<1%	1,889	$9K
73100		<1%	3,338	$9K
83001		<1%	1,016	$9K
82784		<1%	3,275	$9K
12001		<1%	2,130	$9K
83002		<1%	1,081	$9K
86235		<1%	215	$8K
87631		<1%	309	$8K
88304		<1%	3,072	$8K
97799		<1%	2,262	$8K
84403		<1%	876	$8K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	2,054	$8K
97166		<1%	780	$8K
86160		<1%	1,490	$8K
81003		<1%	5,065	$8K
82465		<1%	3,041	$8K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	171	$7K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,740	$7K
77074		<1%	826	$7K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,138	$7K
X3920		<1%	146	$7K
83519		<1%	1,117	$7K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,641	$7K
86003		<1%	441	$7K
82947		<1%	5,099	$7K
99080		<1%	916	$7K
A9150	Non-prescription drugs	<1%	16,120	$7K
80143		<1%	675	$7K
72070		<1%	1,325	$7K
76882		<1%	975	$7K
51741		<1%	2,031	$7K
10060		<1%	1,223	$6K
85045		<1%	4,293	$6K
93320		<1%	160	$6K
94664		<1%	1,664	$6K
87088		<1%	2,492	$6K
88104		<1%	1,375	$6K
29515		<1%	3,317	$6K
92523		<1%	276	$6K
80179		<1%	662	$6K
83498		<1%	194	$6K
29125		<1%	3,651	$6K
73560		<1%	2,764	$6K
72040		<1%	785	$6K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	494	$6K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	264	$6K
82379		<1%	1,169	$6K
99213	Doctor's office visit, returning patient (routine)	<1%	237	$6K
J7799	Noc drugs, other than inhalation drugs, administered through dme	<1%	5,957	$5K
83516		<1%	1,357	$5K
51798		<1%	1,834	$5K
67311		<1%	195	$5K
99217		<1%	118	$5K
74230		<1%	305	$5K
12051		<1%	630	$5K
77072		<1%	3,124	$5K
29105		<1%	2,315	$5K
Z4314		<1%	253	$5K
V5264	Ear mold/insert, not disposable, any type	<1%	68	$5K
54640		<1%	239	$5K
83540		<1%	2,260	$5K
0305		<1%	954	$4K
T1001	Nursing assessment / evaluation	<1%	1,852	$4K
X3908		<1%	142	$4K
82657		<1%	403	$4K
83550		<1%	2,084	$4K
80061	Lipid panel	<1%	2,428	$4K
76506		<1%	107	$4K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,255	$4K
74240		<1%	164	$4K
87045		<1%	727	$4K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	14	$4K
72170		<1%	340	$4K
74455		<1%	205	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	3,756	$4K
88185		<1%	13	$4K
84244		<1%	129	$4K
87205		<1%	2,407	$4K
0700		<1%	3,151	$4K
99464		<1%	85	$4K
72081		<1%	555	$4K
J9100	Injection, cytarabine, 100 mg	<1%	311	$4K
93971		<1%	49	$4K
86038		<1%	552	$4K
82139		<1%	509	$3K
82670		<1%	342	$3K
90686		<1%	682	$3K
83970		<1%	386	$3K
94060		<1%	554	$3K
99460		<1%	44	$3K
74270		<1%	244	$3K
A9554	Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries	<1%	27	$3K
87799		<1%	175	$3K
99234		<1%	1,608	$3K
80305		<1%	1,199	$3K
92611		<1%	187	$3K
86225		<1%	214	$3K
J8540	Dexamethasone, oral, 0.25 mg	<1%	49	$3K
80076		<1%	817	$3K
96368		<1%	603	$3K
86880		<1%	592	$3K
72146		<1%	39	$3K
82977		<1%	1,034	$3K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	5,120	$3K
X4301		<1%	26	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	531	$2K
29505		<1%	1,052	$2K
82247		<1%	601	$2K
44500		<1%	96	$2K
86308		<1%	827	$2K
V5266	Battery for use in hearing device	<1%	64	$2K
69210		<1%	387	$2K
25605		<1%	210	$2K
99368		<1%	1,943	$2K
86376		<1%	596	$2K
94621		<1%	100	$2K
82533		<1%	538	$2K
99152		<1%	544	$2K
76857		<1%	174	$2K
V5010	Assessment for hearing aid	<1%	27	$2K
S5012	5% dextrose with potassium chloride, 1000 ml	<1%	3,115	$2K
86360		<1%	263	$2K
87300		<1%	845	$2K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	32	$2K
89051		<1%	2,166	$2K
87449		<1%	180	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,645	$2K
86359		<1%	263	$2K
84703		<1%	861	$2K
V5267	Hearing aid or assistive listening device/supplies/accessories, not otherwise specified	<1%	25	$2K
86355		<1%	276	$2K
86039		<1%	122	$2K
82150		<1%	430	$2K
86357		<1%	250	$2K
85060		<1%	486	$2K
73660		<1%	621	$2K
82570		<1%	2,044	$2K
94150		<1%	298	$2K
80069		<1%	1,054	$2K
84510		<1%	129	$2K
A9573	Injection, gadopiclenol, 1 ml	<1%	24	$1K
S9470	Nutritional counseling, dietitian visit	<1%	316	$1K
Z7508		<1%	25	$1K
J2060	Injection, lorazepam, 2 mg	<1%	274	$1K
X3910		<1%	142	$1K
87075		<1%	526	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	127	$1K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	65	$1K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	60	$1K
99284	Emergency room visit (serious)	<1%	50	$1K
29130		<1%	782	$1K
84132		<1%	3,759	$1K
84295		<1%	3,705	$1K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	71	$1K
30140		<1%	81	$1K
71020		<1%	40	$1K
96367		<1%	177	$1K
99239	Hospital discharge day management, more than 30 minutes	<1%	39	$1K
82105		<1%	145	$1K
76937		<1%	180	$1K
96151		<1%	48	$1K
87046		<1%	728	$1K
82785		<1%	804	$1K
82010		<1%	472	$1K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	24	$1K
77076		<1%	38	$1K
93000		<1%	26	$993.02
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	71	$987.11
93308		<1%	30	$986.91
14040		<1%	42	$968.24
99205	Prolong outpt/office vis	<1%	39	$953.38
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	1,854	$952.50
51600		<1%	127	$914.47
87279		<1%	140	$913.14
88342		<1%	71	$894.36
86769		<1%	137	$893.95
92522		<1%	102	$857.58
X4540		<1%	26	$855.66
S9446	Patient education, not otherwise classified, non-physician provider, group, per session	<1%	929	$854.05
93350		<1%	63	$836.59
84030		<1%	129	$788.19
86945		<1%	457	$764.10
80164		<1%	242	$755.34
J0290	Injection, ampicillin sodium, 500 mg	<1%	133	$750.05
82157		<1%	49	$750.00
82140		<1%	171	$700.74
92551		<1%	69	$684.32
84156		<1%	1,387	$683.00
90656		<1%	63	$672.57
11750		<1%	90	$652.53
S5001	Prescription drug, brand name	<1%	514	$651.89
X4100		<1%	13	$649.61
72141		<1%	37	$647.01
80320		<1%	609	$642.60
0761		<1%	42	$627.16
24640		<1%	216	$621.39
86431		<1%	172	$591.70
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	<1%	335	$574.80
87299		<1%	137	$574.39
87260		<1%	137	$563.64
86256		<1%	163	$556.65
84480		<1%	152	$548.35
92015	Determination of refractive state	<1%	47	$544.63
11730		<1%	138	$543.90
76942		<1%	27	$527.28
Z4303		<1%	12	$516.36
87280		<1%	137	$509.48
J7609	Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg	<1%	968	$494.17
12031		<1%	50	$485.99
88300		<1%	456	$460.09
80197		<1%	73	$448.48
93786		<1%	57	$438.28
83520		<1%	169	$426.26
86356		<1%	68	$423.62
J1953	Injection, levetiracetam, 10 mg	<1%	25	$411.61
83655		<1%	446	$411.58
86665		<1%	80	$402.03
82610		<1%	103	$388.80
0302		<1%	347	$381.93
88184		<1%	13	$370.22
84436		<1%	1,535	$361.10
93321		<1%	32	$355.57
88307		<1%	66	$352.82
74241		<1%	26	$343.25
J1071	Injection, testosterone cypionate, 1 mg	<1%	33	$339.21
94729		<1%	12	$337.40
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	118	$335.29
82652		<1%	99	$330.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,285	$322.81
86329		<1%	101	$300.87
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	94	$293.91
70250		<1%	24	$292.37
82248		<1%	220	$280.63
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	14	$276.50
30300		<1%	110	$270.50
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	1,998	$269.78
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	339	$250.98
86480		<1%	55	$248.80
71250		<1%	13	$235.21
87276		<1%	134	$233.55
94760		<1%	134	$217.03
80177		<1%	50	$211.85
87275		<1%	134	$211.33
85397		<1%	14	$208.70
88108		<1%	47	$202.45
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	47	$197.52
73600		<1%	56	$177.30
92585		<1%	19	$176.65
74000		<1%	13	$175.49
82043		<1%	510	$169.51
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	41	$166.29
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	60	$156.63
84460		<1%	27	$152.99
84450		<1%	13	$141.74
86664		<1%	68	$141.55
87427		<1%	43	$140.29
86703		<1%	31	$139.71
82017		<1%	42	$137.15
85240		<1%	13	$133.26
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	184	$132.43
S0077	Injection, clindamycin phosphate, 300 mg	<1%	26	$130.33
86592		<1%	80	$129.08
82962		<1%	74	$127.96
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	16	$120.86
29799		<1%	35	$120.00
92567		<1%	15	$116.04
87106		<1%	67	$115.85
84478		<1%	104	$107.93
75565		<1%	12	$101.78
87181		<1%	287	$101.63
86317		<1%	12	$92.25
96523		<1%	40	$90.64
88311		<1%	68	$88.80
24538		<1%	12	$85.77
12002		<1%	24	$80.04
70160		<1%	12	$78.76
86645		<1%	12	$75.67
85018		<1%	34	$74.10
0257		<1%	12	$73.48
J3475	Injection, magnesium sulfate, per 500 mg	<1%	16	$72.05
S0028	Injection, famotidine, 20 mg	<1%	1,164	$67.38
73620		<1%	15	$67.34
J7610	Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg	<1%	53	$61.36
95831		<1%	13	$56.71
86644		<1%	12	$52.18
42830		<1%	40	$50.00
87206		<1%	42	$49.32
E0780	Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours	<1%	165	$48.38
96376		<1%	161	$48.30
87116		<1%	40	$47.66
0320		<1%	1,150	$45.20
80349		<1%	112	$43.05
84146		<1%	13	$42.26
82607		<1%	12	$41.26
82542		<1%	15	$37.91
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	<1%	2,098	$35.70
85008		<1%	614	$33.68
85347		<1%	13	$22.35
83525		<1%	38	$22.00
36415	Collection of venous blood by venipuncture	<1%	12	$20.85
J7510	Prednisolone oral, per 5 mg	<1%	28	$20.26
J2251	Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg	<1%	126	$19.20
84630		<1%	12	$13.00
84702		<1%	17	$8.00
J3370	Injection, vancomycin hcl, 500 mg	<1%	15	$7.07
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	87	$2.54
89050		<1%	15	$1.88
0272		<1%	191	$0.01
0351		0%	90	$0.00
93041		0%	69	$0.00
80339		0%	57	$0.00
0261		0%	158	$0.00
0402		0%	642	$0.00
15853		0%	36	$0.00
99001		0%	55	$0.00
0483		0%	23	$0.00
0260		0%	423	$0.00
0460		0%	51	$0.00
0940		0%	62	$0.00
0444		0%	22	$0.00
81205		0%	15	$0.00
0920		0%	18	$0.00
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	59	$0.00
S5010	5% dextrose and 0.45% normal saline, 1000 ml	0%	29	$0.00
94070		0%	13	$0.00
A4641	Radiopharmaceutical, diagnostic, not otherwise classified	0%	27	$0.00
0611		0%	83	$0.00
0370		0%	2,320	$0.00
80329		0%	215	$0.00
0740		0%	88	$0.00
0310		0%	205	$0.00
99153	Mod sedat endo service >5yrs	0%	41	$0.00
0612	Calcium glucon (wg critical)	0%	39	$0.00
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	0%	29	$0.00
J1094	Injection, dexamethasone acetate, 1 mg	0%	84	$0.00
0410		0%	60	$0.00
0331		0%	122	$0.00
S0074	Injection, cefotetan disodium, 500 mg	0%	20	$0.00
0610		0%	44	$0.00
0352		0%	51	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	17	$0.00
94761		0%	15	$0.00
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	0%	12	$0.00
0942		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGODAMBE, SANDIP (SR. VICE PRESIDENT MEDICAL AFFAIRS)